John F. Neylan
2016
In 2016, John F. Neylan earned a total compensation of $1M as Chief Medical Officer at Keryx Biopharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
Bonus | $11,100 |
---|---|
Non-Equity Incentive Plan | $140,080 |
Option Awards | $251,765 |
Salary | $413,061 |
Stock Awards | $180,063 |
Other | $4,592 |
Total | $1,000,681 |
Neylan received $413.1K in salary, accounting for 41% of the total pay in 2016.
Neylan also received $11.1K in bonus, $140.1K in non-equity incentive plan, $251.8K in option awards, $180.1K in stock awards and $4.6K in other compensation.
Rankings
In 2016, John F. Neylan's compensation ranked 8,259th out of 14,075 executives tracked by ExecPay. In other words, Neylan earned more than 41.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,259 | 41st |
Manufacturing | 3,162 | 42nd |
Chemicals And Allied Products | 1,061 | 44th |
Drugs | 826 | 46th |
Pharmaceutical Preparations | 654 | 44th |
Neylan's colleagues
We found three more compensation records of executives who worked with John F. Neylan at Keryx Biopharmaceuticals in 2016.